Skip to content
value.today

Metamark Genetics, Inc.

🇺🇸 Princeton, New Jersey, USABiotechnologyFounded 2007
Total raised
$34 M
3 rounds on record
Latest round
$9 M
Nov 2012
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Metamark Genetics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2012$9 MNo. 3$2 to $10 million

Metamark Genetics, Inc.: Raise no. 3, Nov 2012

Investors in this round

10 investors had bought by the notice of Nov 15, 2012: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David E. Cordo · Executive Officer
  • Gregory C. Critchfield · Director
  • Kenneth E. Weg · Director
  • Mansoor Raza Mirza · Director
  • Michael C. Kauffman · Director
  • Norman C. Selby · Director
  • Raju E. Kucherlapati · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth E. Weg, Chairman of the Board. Source: SEC Form D, newest notice filed Nov 15, 2012. Read the notice at the SEC.

equitySEC
Jul 2010$22 MNo. 2$10 to $50 million

Metamark Genetics, Inc.: Raise no. 2, Jul 2010

Investors in this round

3 investors had bought by the notice of Jul 9, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $42 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David E. Cordo · Executive Officer
  • Kenneth E. Weg · Executive Officer, Director
  • Lynda E. Chin · Director
  • Norman C. Selby · Director
  • Raju E. Kucherlapati · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth E. Weg, President, Treasurer and Secretary. Source: SEC Form D, newest notice filed Jul 9, 2010. Read the notice at the SEC.

equitySEC
May 2009$3 MNo. 1$2 to $10 million

Metamark Genetics, Inc.: Raise no. 1, May 2009

Investors in this round

6 investors had bought by the notice of May 8, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $11 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Kenneth E. Weg · Executive Officer, Director
  • Lynda Chin · Director
  • Raju Kucherlapati · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth E. Weg, President, Treasurer and Secretary. Source: SEC Form D, newest notice filed May 8, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Metamark Genetics, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2012).

    SEC Form D · Nov 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2012

That is all the official record says: Metamark Genetics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Metamark Genetics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Metamark Genetics, Inc.
NameRoleNamed in
David E. CordoExecutive officerNov 2012
Kenneth E. WegExecutive officerJul 2010
Gregory C. CritchfieldDirectorNov 2012
Kenneth E. WegDirectorNov 2012
Mansoor Raza MirzaDirectorNov 2012
Michael C. KauffmanDirectorNov 2012
Norman C. SelbyDirectorNov 2012
Raju E. KucherlapatiDirectorNov 2012
Lynda E. ChinDirectorJul 2010
Lynda ChinDirectorMay 2009
Raju KucherlapatiDirectorMay 2009